SEC Form 4 · accession 0001209191-17-022787
CUMBERLAND PHARMACEUTICALS INC · CPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Bonner
Officer — Chief Financial Officer
Period of report
Mar 23, 2017
Accepted (ET)
Mar 24, 2017 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001087294
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 23, 2017 | P | 900 | $6.42 | A | 12,800 | D |
Table II — derivative securities
No Table II lines on this filing.